Literature DB >> 30378301

[Soluble Uric Acid Activates NLRP3 Inflammasome in Myocardial Cells Through Down-regulating UCP2].

Guan-Li Wang1, Hong-Min Yuan2, Zhen-Feng Wang1, Bei-Bei Zong1, Yang Ye1, Jun Zhang1, Hai-Long Zhang1.   

Abstract

OBJECTIVE: To determine the H9C2 cell damage and NLRP3 inflammasome activation trigged by soluble uric acid (UA).
METHODS: H9C2 cells were treated with UA. The cellular damage was examined after 12 h, 24 h and 48 h of treatment using MTS and lactic dehydrogenase (LDH). The apoptosis of H9C2 cells was analyzed by flow cytometry (FCM). NLRP3 inflammasome activation was reflected by the protein levels of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC) and Caspase-1 detected by Western blot. The mitochondria and cytoplasm were separated and the release of cytochrome C was detected by Western blot to analyze the damage of mitochondria. The impacts of NAC, a ROS inhibitor, on the cell viability and NLRP3 inflammasome activation were analyzed. The expression of UCP2 was detected by Western blot and immunofluorescence (IF).
RESULTS: Dose response and time dependent effects of UA on cellular damage and cell apoptosis was observed. UA up-regulated the expression of NLRP3 inflammasome-related molecules. UA damaged the mitochondria. NAC improved the cell viability and inhibited NLRP3 inflammasome activation. UA down-regulated the expression of UCP2.
CONCLUSION: Soluble UA can down-regulate the expression of UCP2, damage the mitochondria and activate NLRP3 inflammasome, resulting in cellular damage of H9C2 cells. Copyright© by Editorial Board of Journal of Sichuan University (Medical Science Edition).

Entities:  

Keywords:  Myocardial cell damagezzm321990; NLRP3 inflammasomezzm321990; Soluble uric acidzzm321990; UCP2zzm321990

Mesh:

Substances:

Year:  2018        PMID: 30378301

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  3 in total

1.  Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation.

Authors:  Qiulan Lv; Daxing Xu; Jinfeng Ma; Yan Wang; Xiaomin Yang; Peng Zhao; Liang Ma; Zhiyuan Li; Wan Yang; Xiu Liu; Guanpin Yang; Shichao Xing
Journal:  Inflamm Res       Date:  2020-10-19       Impact factor: 4.575

Review 2.  Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease.

Authors:  Miao Wang; Xin Lin; Xiaoming Yang; Yanlang Yang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

3.  Ceftriaxone Calcium Crystals Induce Acute Kidney Injury by NLRP3-Mediated Inflammation and Oxidative Stress Injury.

Authors:  Zhang Yifan; Ning Benxiang; Xu Zheng; Xu Luwei; Zhou Liuhua; Ge Yuzheng; Jia Ruipeng
Journal:  Oxid Med Cell Longev       Date:  2020-07-09       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.